Publications found:
47,216
Sort by:
Emerging In Vitro Diagnostic Technologies and Their Potential Applications
US$ 4,500.00
... assessments of emerging in vitro diagnostic technologies and their potential applications within the following market segments: Blood Typing, Grouping, and Screening Cancer Diagnostic Clinical Chemistry and Immunodiagnostics Coagulation Testing Hematology and Flow Cytometry Microbiology Molecular Diagnostics Technologies analyzed in the ...
November 2021
-
Emerging Molecular Diagnostics Market: Innovative Technologies and Strategic Profiles of Leading Suppliers
US$ 4,500.00
... report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection ... strategic assessments of current and emerging suppliers of molecular diagnostics products, including their sales, product portfolios, marketing tactics, technological know-how, new products ...
November 2021
-
Emerging Microbiology Market: Innovative Technologies and Strategic Profiles of Leading Suppliers
US$ 4,500.00
... provides detailed analyses of current and emerging technologies, and their potential applications for the microbiology testing market, including molecular diagnostics, biochips, monoclonal ... others. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their ...
November 2021
-
2021-2025 Asia-Pacific Tumor Markers Business Opportunities in 17 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
-
2021-2025 Europe Tumor Markers Business Opportunities-France, Germany, Italy, Spain, UK-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major...
November 2021
-
2021-2025 Europe Tumor Markers Business Opportunities in 38 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
-
2021-2025 France Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the Fre...
November 2021
-
2021-2025 Germany Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the Ger...
November 2021
-
2021-2025 Global Tumor Markers Business Opportunities-USA, Europe, Japan-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 24,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S...
November 2021
-
2021-2025 Italy Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the It...
November 2021
-
2021-2025 Japan Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Japanese cancer diagnostics market during the next five years. The report examines trends in the J...
November 2021
-
2021-2025 Latin America Tumor Markers Business Opportunities in 22 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 14,500.00
This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
-
2021-2025 Middle East Tumor Markers Business Opportunities in 11 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific in...
November 2021
-
2021-2025 North America Tumor Markers Business Opportunities-USA, Canada, Mexico-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 9,500.00
This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. The report is available by section, and can be customized to specific inf...
November 2021
-
2021-2025 Spain Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the Spanish cancer diagnostics market during the next five years. The report examines trends in the Sp...
November 2021
-
2021-2025 U.K. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK canc...
November 2021
-
2021-2025 U.S. Tumor Markers Business Opportunities-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 3,500.00
LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the U.S. cancer diagnostics market during the next five years. The report examines trends in the U.S....
November 2021
-
2021-2025 World Tumor Markers Business Opportunities in 97 Countries-Oncogenes, Bio Markers, GFs, CSFs, Hormones, Stains, Lymphokines-Competitive Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 34,500.00
This new 97-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. The report is available by section, and can be customized to spe...
November 2021
-
Europe Molecular Diagnostics Market Assessment-France, Germany, Italy, Spain, UK-2021-2025 Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests-Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
US$ 17,500.00
This new comprehensive five-country report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities eme...
November 2021
-
